FONT-SIZE Plus   Neg

Collegium Pharmaceutical Holding On To Significant Gain

Shares of Collegium Pharmaceutical (COLL) have pulled back off their best levels of the day but continue to see significant strength in afternoon trading on Thursday. Collegium is currently up by 11.8 percent after reaching a two-month intraday high.

The jump comes after Cigna (CI) said it has signed a value-based contract with Collegium Pharmaceutical for its oxycodone equivalent Xtampza ER after ending coverage of opioid painkiller OxyContin.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
World's largest oil company Saudi Aramco's initial public offering is on track and the listing will be in the second half of 2018, CEO Amin Nasser said in an exclusive interview with CNBC. There have been reports that the much awaited IPO might be delayed by one year. Taco Bell, the Mexican fast food chain of Yum! Brands Inc., is reportedly testing a new dessert product called the "Kit Kat Chocoladilla" at select locations in Wisconsin. It was tested last year in the UK. Nick Caporella, the chief executive officer of National Beverage Corp., has lashed out at short sellers after his company's shares declined more than 22 percent this month from their September 11 peak. In a statement, Caporella noted that less than 15 percent of the daily volume traded on major exchanges is financially driven by company fundamentals.
comments powered by Disqus
Follow RTT